CASSAVA SCIENCES INC's ticker is SAVA and the CUSIP is 14817C107. A total of 173 filers reported holding CASSAVA SCIENCES INC in Q1 2022. The put-call ratio across all filers is 1.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50 | -71.9% | 9,900 | -43.4% | 0.01% | -75.0% |
| Q2 2023 | $178 | -11.9% | 17,500 | -45.8% | 0.02% | +14.3% |
| Q1 2023 | $202 | -83.5% | 32,300 | -79.3% | 0.02% | -79.8% |
| Q4 2022 | $1,223 | -99.9% | 156,400 | -1.0% | 0.10% | -30.7% |
| Q3 2022 | $2,189,000 | +99.7% | 158,000 | +47.3% | 0.15% | +94.8% |
| Q2 2022 | $1,096,000 | -9.0% | 107,260 | -10.1% | 0.08% | +22.2% |
| Q1 2022 | $1,205,000 | +31.1% | 119,300 | -18.5% | 0.06% | +61.5% |
| Q4 2021 | $919,000 | -63.2% | 146,300 | -36.3% | 0.04% | -65.2% |
| Q3 2021 | $2,494,000 | -4.3% | 229,712 | +97.2% | 0.11% | -8.2% |
| Q2 2021 | $2,605,000 | +141.0% | 116,498 | +33.8% | 0.12% | +130.2% |
| Q1 2021 | $1,081,000 | +3503.3% | 87,096 | +1031.1% | 0.05% | +5200.0% |
| Q4 2020 | $30,000 | -65.9% | 7,700 | -54.0% | 0.00% | -80.0% |
| Q3 2020 | $88,000 | +450.0% | 16,725 | -36.6% | 0.01% | +400.0% |
| Q2 2020 | $16,000 | 0.0% | 26,400 | +500.0% | 0.00% | 0.0% |
| Q1 2020 | $16,000 | – | 4,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bleichroeder LP | 1,739,540 | $7,150,000 | 1.87% |
| SPHERA FUNDS MANAGEMENT LTD. | 615,000 | $2,528,000 | 0.32% |
| Worth Venture Partners, LLC | 48,535 | $200,000 | 0.12% |
| Ikarian Capital, LLC | 300,000 | $1,233,000 | 0.09% |
| Orbimed Advisors | 250,000 | $1,530,000 | 0.03% |
| Quinn Opportunity Partners LLC | 35,687 | $147,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 38,356 | $158,000 | 0.01% |
| Jefferies Group LLC | 80,000 | $329,000 | 0.00% |
| ClariVest Asset Management LLC | 33,403 | $137,000 | 0.00% |
| Renaissance Technologies | 653,759 | $2,687,000 | 0.00% |